MsParamita Chakrabarty

Exploration of Compounds that Modulate Protein Phosphatase 2A to Treat Parkinson’s Disease

Evaluation of the neuroimmune mechanisms influencing therapeutic targeting potential of the LH/CG receptor in the menopausal and AD brain

Sepsis and the Systemic Cytokine Storm in Aging and Alzheimer Disease Models

Contribution of CASP8 GGGAGA repeat expansion in Alzheimer's disease

Can SARS-CoV-2 proteins accelerate Abeta pathology in fly and mouse models of AD?

Rest/Active Phase Specificity of APOE4 and Inflammation on Respiratory Plasticity

Brain metabolism and genetic risk factors: An imaging study in AD Mice

Intersection of GBA and LRRK2 in Lewy Body Dementia

Clinical and Translational Pre-doctoral training in Alzheimer’s Disease and Related Dementias

Exploration of compounds that target alpha-synuclein phosphorylation

Molecular mechanisms of alpha-synuclein induction and spread of pathobiology

Genetic rescue of tau neuropathology in AAV-tau-injected mice

Deciphering tau phosphorylation and Abeta/tau strain interactions in Alzheimer’s pathogenesis

Sepsis and the Systemic Cytokine Storm in Aging and Alzheimer Disease Models

Assessing the Role of the APOE Genotype in Traumatic Brain Injury

Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia

Modeling the progression of SOD1-linked motor neuron disease

Mechanisms and therapeutic potential of vagus nerve stimulation in aging and Alzheimer’s disease

A Systems Approach to Targeting Innate Immunity in AD

Validate PFF a-syn induced inflammatory phenotype in mice.

Age-associated impaired executive function: Rescue by NMDA receptor upregulation

Developing a tau based NHP model of AD

A tau-based monkey model of Alzheimer’s Disease

Metabolic Interventions for Enhancing Cognitive Resilience in Aging and Alzheimers Disease.

Mechanisms of abnormal neuronal tau accumulation, interactions with amyloid-beta and pathological sequelae